109 related articles for article (PubMed ID: 25374063)
1. DNA repair gene polymorphisms and clinical outcome of patients with primary small cell carcinoma of the esophagus.
Zhou Q; Zou BW; Xu Y; Xue JX; Meng MB; Liu FJ; Deng L; Ma DY; Ao R; Lu Y
Tumour Biol; 2015 Mar; 36(3):1539-48. PubMed ID: 25374063
[TBL] [Abstract][Full Text] [Related]
2. Polymorphism in DNA repair genes and oral squamous cell carcinoma in Thailand.
Kietthubthew S; Sriplung H; Au WW; Ishida T
Int J Hyg Environ Health; 2006 Jan; 209(1):21-9. PubMed ID: 16373199
[TBL] [Abstract][Full Text] [Related]
3. DNA-repair gene polymorphisms predict favorable clinical outcome among patients with advanced squamous cell carcinoma of the head and neck treated with cisplatin-based induction chemotherapy.
Quintela-Fandino M; Hitt R; Medina PP; Gamarra S; Manso L; Cortes-Funes H; Sanchez-Cespedes M
J Clin Oncol; 2006 Sep; 24(26):4333-9. PubMed ID: 16896002
[TBL] [Abstract][Full Text] [Related]
4. Polymorphisms in DNA repair genes in the molecular pathogenesis of esophageal (Barrett) adenocarcinoma.
Casson AG; Zheng Z; Evans SC; Veugelers PJ; Porter GA; Guernsey DL
Carcinogenesis; 2005 Sep; 26(9):1536-41. PubMed ID: 15878910
[TBL] [Abstract][Full Text] [Related]
5. Polymorphisms in the base excision repair pathway modulate prognosis of platinum-based chemotherapy in advanced non-small cell lung cancer.
Zhao W; Hu L; Xu J; Shen H; Hu Z; Ma H; Shu Y; Shao Y; Yin Y
Cancer Chemother Pharmacol; 2013 May; 71(5):1287-95. PubMed ID: 23479135
[TBL] [Abstract][Full Text] [Related]
6. Nucleotide excision repair gene polymorphisms and recurrence after treatment for superficial bladder cancer.
Gu J; Zhao H; Dinney CP; Zhu Y; Leibovici D; Bermejo CE; Grossman HB; Wu X
Clin Cancer Res; 2005 Feb; 11(4):1408-15. PubMed ID: 15746040
[TBL] [Abstract][Full Text] [Related]
7. Polymorphisms in DNA repair and apoptosis-related genes and clinical outcomes of patients with non-small cell lung cancer treated with first-line paclitaxel-cisplatin chemotherapy.
Lee SY; Kang HG; Yoo SS; Kang YR; Choi YY; Lee WK; Choi JE; Jeon HS; Shin KM; Oh IJ; Kim KS; Lee J; Cha SI; Kim CH; Kim YC; Park JY
Lung Cancer; 2013 Nov; 82(2):330-9. PubMed ID: 23973201
[TBL] [Abstract][Full Text] [Related]
8. DNA repair gene polymorphisms predict favorable clinical outcome in advanced non-small-cell lung cancer.
Kalikaki A; Kanaki M; Vassalou H; Souglakos J; Voutsina A; Georgoulias V; Mavroudis D
Clin Lung Cancer; 2009 Mar; 10(2):118-23. PubMed ID: 19362955
[TBL] [Abstract][Full Text] [Related]
9. Glioma risk associates with polymorphisms of DNA repair genes, XRCC1 and PARP1.
Yosunkaya E; Kucukyuruk B; Onaran I; Gurel CB; Uzan M; Kanigur-Sultuybek G
Br J Neurosurg; 2010 Oct; 24(5):561-5. PubMed ID: 20868244
[TBL] [Abstract][Full Text] [Related]
10. Single nucleotide polymorphisms in DNA repair genes XRCC1 and APEX1 in progression and survival of primary cutaneous melanoma patients.
Figl A; Scherer D; Nagore E; Bermejo JL; Dickes E; Thirumaran RK; Gast A; Hemminki K; Kumar R; Schadendorf D
Mutat Res; 2009 Feb; 661(1-2):78-84. PubMed ID: 19073198
[TBL] [Abstract][Full Text] [Related]
11. Polymorphisms in XRCC1, XRCC3, and CCND1 and survival after treatment for metastatic breast cancer.
Bewick MA; Conlon MS; Lafrenie RM
J Clin Oncol; 2006 Dec; 24(36):5645-51. PubMed ID: 17116943
[TBL] [Abstract][Full Text] [Related]
12. Xeroderma pigmentosum complementation group C single-nucleotide polymorphisms in the nucleotide excision repair pathway correlate with prolonged progression-free survival in advanced ovarian cancer.
Fleming ND; Agadjanian H; Nassanian H; Miller CW; Orsulic S; Karlan BY; Walsh CS
Cancer; 2012 Feb; 118(3):689-97. PubMed ID: 21751198
[TBL] [Abstract][Full Text] [Related]
13. Single nucleotide polymorphisms in DNA repair genes might be prognostic factors in muscle-invasive bladder cancer patients treated with chemoradiotherapy.
Sakano S; Wada T; Matsumoto H; Sugiyama S; Inoue R; Eguchi S; Ito H; Ohmi C; Matsuyama H; Naito K
Br J Cancer; 2006 Sep; 95(5):561-70. PubMed ID: 16880786
[TBL] [Abstract][Full Text] [Related]
14. DNA repair gene and MTHFR gene polymorphisms as prognostic markers in locally advanced adenocarcinoma of the esophagus or stomach treated with cisplatin and 5-fluorouracil-based neoadjuvant chemotherapy.
Ott K; Rachakonda PS; Panzram B; Keller G; Lordick F; Becker K; Langer R; Buechler M; Hemminki K; Kumar R
Ann Surg Oncol; 2011 Sep; 18(9):2688-98. PubMed ID: 21347786
[TBL] [Abstract][Full Text] [Related]
15. Significance of amino acid substitution variants of DNA repair genes in radiosusceptibility of cervical cancer patients; a pilot study.
Farkasova T; Gurska S; Witkovsky V; Gabelova A
Neoplasma; 2008; 55(4):330-7. PubMed ID: 18505345
[TBL] [Abstract][Full Text] [Related]
16. DNA repair genes XPC, XPG polymorphisms: relation to the risk of colorectal carcinoma and therapeutic outcome with Oxaliplatin-based adjuvant chemotherapy.
Liu D; Wu HZ; Zhang YN; Kang H; Sun MJ; Wang EH; Yang XL; Lian MQ; Yu ZJ; Zhao L; Olopade OI; Wei MJ
Mol Carcinog; 2012 Oct; 51 Suppl 1():E83-93. PubMed ID: 22213216
[TBL] [Abstract][Full Text] [Related]
17. Polymorphisms of DNA repair genes are associated with renal cell carcinoma.
Hirata H; Hinoda Y; Matsuyama H; Tanaka Y; Okayama N; Suehiro Y; Zhao H; Urakami S; Kawamoto K; Kawakami T; Igawa M; Naito K; Dahiya R
Biochem Biophys Res Commun; 2006 Apr; 342(4):1058-62. PubMed ID: 16510122
[TBL] [Abstract][Full Text] [Related]
18. Polymorphisms of DNA repair genes and risk of non-small cell lung cancer.
Zienolddiny S; Campa D; Lind H; Ryberg D; Skaug V; Stangeland L; Phillips DH; Canzian F; Haugen A
Carcinogenesis; 2006 Mar; 27(3):560-7. PubMed ID: 16195237
[TBL] [Abstract][Full Text] [Related]
19. Genetic variations in radiation and chemotherapy drug action pathways predict clinical outcomes in esophageal cancer.
Wu X; Gu J; Wu TT; Swisher SG; Liao Z; Correa AM; Liu J; Etzel CJ; Amos CI; Huang M; Chiang SS; Milas L; Hittelman WN; Ajani JA
J Clin Oncol; 2006 Aug; 24(23):3789-98. PubMed ID: 16785472
[TBL] [Abstract][Full Text] [Related]
20. Identification of genetic variants in base excision repair pathway and their associations with risk of esophageal squamous cell carcinoma.
Hao B; Wang H; Zhou K; Li Y; Chen X; Zhou G; Zhu Y; Miao X; Tan W; Wei Q; Lin D; He F
Cancer Res; 2004 Jun; 64(12):4378-84. PubMed ID: 15205355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
